![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/citius-pharmaceuticals-inc-reports-fiscal-third-quarter-2024-financial-results-and-provides-business-update-302220367.html
https://www.prnewswire.com/news-releases/citius-pharmaceuticals-completes-merger-of-subsidiary-with-tenx-keane-to-form-citius-oncology-inc-302220303.html
https://www.prnewswire.com/news-releases/citius-pharmaceuticals-to-host-investor-call-to-discuss-recent-and-upcoming-developments-302219218.html
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-citius-blood-cancer-therapy-2024-08-08/#:~:text=Aug%208%20(Reuters)%20%2D%20The,the%20regulator%20rejected%20the%20treatment
https://www.prnewswire.com/news-releases/citius-pharmaceuticals-announces-tenx-keane-shareholder-approval-of-merger-with-citius-oncology-inc-302214116.html
https://www.prnewswire.com/news-releases/citius-pharmaceuticals-details-near-term-milestones-for-late-stage-candidates-302192605.html
https://www.prnewswire.com/news-releases/citius-pharmaceuticals-to-host-investor-call-to-discuss-topline-results-of-phase-3-trial-of-mino-lok-antibiotic-lock-solution-302157598.html
https://www.prnewswire.com/news-releases/citius-pharmaceuticals-achieves-primary-and-secondary-endpoints-in-phase-3-trial-of-mino-lok-antibiotic-lock-solution-302150869.html
https://www.prnewswire.com/news-releases/citius-pharmaceuticals-inc-reports-fiscal-second-quarter-2024-financial-results-and-provides-business-update-302145338.html
https://www.prnewswire.com/news-releases/citius-pharmaceuticals-to-participate-in-upcoming-ef-hutton-and-hc-wainwright-investor-conferences-302141737.html